Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)

Published: April 11, 2025 | Price: $5,600.00 – $8,000.00

The Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030) report by Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge in new therapies and a promising pipeline, with significant clinical trial activity across various therapeutic areas, including oncology and cardiology. This comprehensive report segments the market...

In Vitro Diagnostics Business Outlook, 2025 (6 Issues)

Published: April 3, 2025 | Price: $5,250.00 – $7,500.00

The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions. As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater. In Vitro Diagnostics Business...

30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025

Published: March 25, 2025 | Price: $5,600.00 – $8,000.00

Updated quarterly (four times a year) to reflect market changes   Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape. Leveraging over two decades of...

The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025

Published: February 14, 2025 | Price: $5,600.00 – $8,000.00

Kalorama Information’s The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025 provides a comprehensive analysis of the global HbA1c testing market, highlighting key trends, technological advancements, and growth opportunities. This report delves into the geographical distribution, demographic influences, and critical market issues shaping the industry. It offers a detailed examination of market values, regional dynamics, and competitive landscapes, with insights into leading providers. Since the 1990s, HbA1c testing has been pivotal in monitoring long-term glycemic control in...

The World Market for Veterinary Diagnostics, 8th Edition

Published: January 30, 2025 | Price: $5,600.00 – $8,000.00

If you’re looking to navigate the complex and fast-growing veterinary diagnostics landscape, The World Market for Veterinary Diagnostics, 8th Edition is your essential guide. Packed with actionable intelligence, industry trends, and market projections, this report equips you with the knowledge to make informed business decisions and seize emerging opportunities in this high-growth sector.   The veterinary diagnostics industry is undergoing a period of rapid expansion, driven by advancements in in vitro diagnostic (IVD) technology, increasing pet ownership, and the growing...

30-Country IVD Market Atlas, 2024 (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries) [December 2024 update]

Published: December 23, 2024 | Price: $5,000.00 – $10,500.00

Now in its fourth and final update in 2024!   What’s Included One Report Covering 30 Countries Sizing for 20 Important IVD Market Segments Segments Estimated for Each Country Forecasts to 2028 for Each Segment Updated Quarterly (4 updates annually) to Reflect Market Changes Over 2800 Data Points About the Report With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information understands the importance of global coverage and the need for more detailed geographic...

The World Market for Molecular Diagnostics, 13th Edition

Published: December 19, 2024 | Price: $3,950.00 – $7,875.00

The molecular diagnostics market, a driving force within the global in vitro diagnostics (IVD) industry, continues to thrive several years post-pandemic, offering significant growth opportunities across infectious diseases, cancer, and transplant diagnostics. Kalorama Information's latest report, The World Market for Molecular Diagnostics, 13th Edition, provides an unparalleled deep dive into this dynamic sector, revealing key trends, applications, and innovations shaping the market from 2024 to 2029. Why This Report is a Must-Have: Comprehensive Market Insights: Analyze global and regional molecular...

Molecular Diagnostics Quarterly Datastream, 2024

Published: November 30, 2024 | Price: $10,500.00

NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.   The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...

Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029

Published: November 19, 2024 | Price: $6,300.00 – $12,600.00

Stay Ahead of the Curve with Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029: With the global demand for infectious disease IVD products projected to surge, understanding market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern.   Abstract As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool...

IVD Test Procedure Volumes, 2024-2029

Published: October 8, 2024 | Price: $6,300.00 – $12,600.00

Act Now – Be Prepared for Tomorrow’s IVD Market Don’t miss your chance to leverage Kalorama Information’s expert insights. Equip your business with the knowledge to anticipate changes, optimize product development, and maximize your strategies in the dynamic IVD landscape. Ready to take action? Purchase the IVD Test Procedure Volumes, 2024-2029 report today and secure your competitive advantage in this billion-dollar industry.   Abstract Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends...

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition

Published: August 29, 2024 | Price: $8,750.00 – $17,500.00

Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume. Key Features: Extensive Coverage: Detailed estimates and...

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028

Published: July 26, 2024 | Price: $5,000.00 – $10,500.00

Kalorama Information’s latest report, The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028, is now available for purchase. This comprehensive study delves into the dynamic landscape of LDTs, exploring both the services market and the market for test products sold to clinical laboratories. The Worldwide Market for Laboratory-Developed Tests includes comprehensive analysis of the effects of the FDA's new "Medical Devices: Laboratory Developed Tests" rule, passed in April 2024, which subjects LDTs to significantly greater regulatory oversight. Inclusion Criteria for LDTs: 2023-2024: LDTs...

Cell and Gene Therapy Deals Analysis, 2021-2024

Published: June 3, 2024 | Price: $6,300.00 – $12,600.00

Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 is published in two installments, the first in Q2 2024 and the second in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that...

Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029

Published: April 30, 2024 | Price: $5,000.00 – $10,500.00

Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system.  Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue.  A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials. Cell...

The Market for Molecular Point-of-Care (mPOC), 2024

Published: March 7, 2024 | Price: $5,000.00 – $10,500.00

Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...

The World Market for Vaccines, 2024

Published: February 22, 2024 | Price: $5,000.00 – $10,500.00

Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related deaths are now rare in developed nations and decreasing globally. Smallpox has been eradicated, polio eliminated...

The Worldwide Market for Liquid Biopsy, 6th Edition

Published: December 29, 2023 | Price: $5,000.00 – $10,000.00

Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...

Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023

Published: December 8, 2023 | Price: $5,000.00 – $10,000.00

While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years.  Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area.  There are now many approved therapies with proven track records. As the technologies have lowered the barriers to entry for the industry, over 1,500 therapy or tools companies have been...

Remote Patient Monitoring and Telehealth Markets, 13th Edition

Published: November 27, 2023 | Price: $5,000.00 – $10,000.00

Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote...

30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

Published: October 27, 2023 | Price: $5,000.00 – $10,000.00

In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning.  Kalorama's 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning. Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has...

World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027

Published: October 18, 2023 | Price: $6,000.00 – $12,000.00

Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and healthcare-related laboratories, including clinical and analytical laboratories. These include research and development labs, in-process testing labs and quality assurance labs. This new report from Kalorama Information, World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027, examines the current and potential world opportunity for healthcare laboratory information system (LIS) software, hardware, and implementation....

The Market for RNA Sequencing, 3rd Edition

Published: September 8, 2023 | Price: $5,000.00 – $10,000.00

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.  Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...

Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition

Published: July 13, 2023 | Price: $3,750.00 – $7,500.00

A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type,...